novel therapeutic strategies in all
Published 2 weeks ago • 26 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:15
key unmet needs in t-cell lymphoma: developing novel therapeutic strategies to improve outcomes
-
3:04
applying molecular understanding of dlbcl to management strategies
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
7:16
changes in the classification of dlbcl
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
2:00
novel treatment strategies in myelofibrosis
-
9:25
mgus diagnosis: a step-by-step approach
-
4:10
the management of prefibrotic myelofibrosis
-
12:30
anemia and myelofibrosis: optimizing diagnosis, treatment, and management strategies
-
0:42
targeted therapies for dlbcl treatment
-
1:05
reprogramming leukemia cells into apcs as a novel therapeutic strategy for b-all
-
1:15
personalized medicine for dlbcl
-
1:53
how novel agents may eliminate the need for transplant in all
-
1:50
the value of moving novel agents into the frontline setting in all
-
3:24
novel agents for the management of r/r myeloma
-
3:21
safety management of car-t cell therapy in dlbcl
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl